Corteva, Inc. (NYSE:CTVA) Shares Sold by Schroder Investment Management Group

Schroder Investment Management Group trimmed its holdings in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 1.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 104,986 shares of the company’s stock after selling 2,073 shares during the period. Schroder Investment Management Group’s holdings in Corteva were worth $5,938,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of CTVA. Allianz SE acquired a new stake in Corteva in the fourth quarter worth approximately $1,459,000. Allstate Corp bought a new stake in shares of Corteva in the 4th quarter worth $1,179,000. Brown Brothers Harriman & Co. lifted its holdings in shares of Corteva by 1.0% in the fourth quarter. Brown Brothers Harriman & Co. now owns 45,128 shares of the company’s stock valued at $2,570,000 after buying an additional 427 shares during the period. RiverFront Investment Group LLC boosted its stake in Corteva by 43.7% during the fourth quarter. RiverFront Investment Group LLC now owns 16,721 shares of the company’s stock valued at $952,000 after buying an additional 5,081 shares in the last quarter. Finally, DnB Asset Management AS grew its holdings in Corteva by 39.0% during the fourth quarter. DnB Asset Management AS now owns 232,902 shares of the company’s stock worth $13,266,000 after acquiring an additional 65,334 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. BNP Paribas raised shares of Corteva to a “hold” rating in a report on Monday, February 10th. UBS Group reduced their target price on shares of Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a report on Friday, January 10th. The Goldman Sachs Group assumed coverage on shares of Corteva in a research report on Thursday, March 13th. They issued a “buy” rating and a $71.00 price target on the stock. Royal Bank of Canada raised their price objective on Corteva from $72.00 to $73.00 and gave the stock an “outperform” rating in a research note on Friday, February 7th. Finally, Wells Fargo & Company lifted their target price on Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and a consensus target price of $68.06.

View Our Latest Stock Report on CTVA

Corteva Trading Down 9.2 %

Shares of NYSE:CTVA opened at $55.66 on Friday. The firm has a fifty day moving average of $62.36 and a two-hundred day moving average of $60.26. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24. The firm has a market capitalization of $38.02 billion, a P/E ratio of 43.15, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73.

Corteva (NYSE:CTVAGet Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, equities analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.22%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s payout ratio is presently 52.71%.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 26,560 shares of the business’s stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares of the company’s stock, valued at $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.